• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections.与非细菌性感染相关的囊性纤维化急性加重的临床表现。
J Pediatr. 1990 Aug;117(2 Pt 1):200-4. doi: 10.1016/s0022-3476(05)80530-x.
2
Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.包括鼻病毒在内的呼吸道病毒感染对囊性纤维化患者临床状况的影响。
Arch Dis Child. 1995 Aug;73(2):117-20. doi: 10.1136/adc.73.2.117.
3
Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis.
J Pediatr. 1989 Feb;114(2):309-14. doi: 10.1016/s0022-3476(89)80804-2.
4
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.囊性纤维化患者呼吸道病毒感染与肺部恶化的关联
N Engl J Med. 1984 Dec 27;311(26):1653-8. doi: 10.1056/NEJM198412273112602.
5
Oxidative stress during acute respiratory exacerbations in cystic fibrosis.囊性纤维化急性呼吸道加重期的氧化应激
Thorax. 1999 Jun;54(6):518-23. doi: 10.1136/thx.54.6.518.
6
Effects of upper respiratory tract infections in patients with cystic fibrosis.囊性纤维化患者上呼吸道感染的影响。
Thorax. 1996 Nov;51(11):1115-22. doi: 10.1136/thx.51.11.1115.
7
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.囊性纤维化患者气道清理的呼气正压物理治疗
Cochrane Database Syst Rev. 2015 Jun 17(6):CD003147. doi: 10.1002/14651858.CD003147.pub4.
8
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.肺动脉增大与囊性纤维化肺部恶化:一项队列研究。
Lancet Respir Med. 2016 Aug;4(8):636-645. doi: 10.1016/S2213-2600(16)30105-9. Epub 2016 Jun 10.
9
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.吸入性抗生素用于囊性纤维化患者的肺部急性加重期
Cochrane Database Syst Rev. 2012 Dec 12;12:CD008319. doi: 10.1002/14651858.CD008319.pub2.
10
A comparison of pulmonary exacerbations with single and multiple organisms in patients with cystic fibrosis and chronic Burkholderia cepacia infection.囊性纤维化和慢性洋葱伯克霍尔德菌感染患者中单一病原体与多种病原体所致肺部加重的比较。
J Infect. 2003 Jan;46(1):56-9. doi: 10.1053/jinf.2001.1077.

引用本文的文献

1
Association between early respiratory viral infections and structural lung disease in infants with cystic fibrosis.早期呼吸道病毒感染与囊性纤维化婴儿结构性肺病的关系。
J Cyst Fibros. 2022 Nov;21(6):1020-1026. doi: 10.1016/j.jcf.2022.04.014. Epub 2022 May 4.
2
Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations.意大利传染病和热带病学会(SIMIT)关于成人疫苗接种的建议。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4265-4282. doi: 10.1080/21645515.2021.1971473. Epub 2021 Sep 15.
3
SPLUNC1: a novel marker of cystic fibrosis exacerbations.SPLUNC1:囊性纤维化加重的新型标志物。
Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.00507-2020. Print 2021 Nov.
4
Infections in cystic fibrosis.囊性纤维化中的感染
Semin Pediatr Infect Dis. 1995 Jul;6(3):174-181. doi: 10.1016/S1045-1870(05)80045-7. Epub 2006 May 31.
5
Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies.阐明囊性纤维化气道上皮细胞与鼻病毒的相互作用:利用宿主-病原体关系确定未来的治疗策略。
Front Pharmacol. 2018 Nov 7;9:1270. doi: 10.3389/fphar.2018.01270. eCollection 2018.
6
Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.呼吸道合胞病毒和流感所致囊性纤维化肺部加重:一项基于人群的研究。
Clin Infect Dis. 2017 Jun 15;64(12):1760-1767. doi: 10.1093/cid/cix203.
7
Respiratory Viral Infections in Chronic Lung Diseases.慢性肺部疾病中的呼吸道病毒感染
Clin Chest Med. 2017 Mar;38(1):87-96. doi: 10.1016/j.ccm.2016.11.014. Epub 2016 Dec 24.
8
Influenza vaccination in children at high risk of respiratory disease.对有患呼吸道疾病高风险的儿童进行流感疫苗接种。
Ther Adv Vaccines. 2013 May;1(1):21-31. doi: 10.1177/2051013613480770.
9
Spectrum of viral infections in patients with cystic fibrosis.囊性纤维化患者的病毒感染谱
Eur J Microbiol Immunol (Bp). 2012 Sep;2(3):161-75. doi: 10.1556/EuJMI.2.2012.3.1. Epub 2012 Sep 10.
10
Pharmacokinetics and diffusion into sputum of oseltamivir and oseltamivir carboxylate in adults with cystic fibrosis.健康成人药代动力学和唾液酸在囊性纤维化中的扩散。
Antimicrob Agents Chemother. 2011 Sep;55(9):4183-7. doi: 10.1128/AAC.00371-11. Epub 2011 Jun 13.

本文引用的文献

1
Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.对105例囊性纤维化患者进行的长期研究;研究历时5至14年。
AMA J Dis Child. 1958 Jul;96(1):6-15. doi: 10.1001/archpedi.1958.02060060008002.
2
Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.囊性纤维化患者由病毒、衣原体和支原体引起的呼吸道感染——与铜绿假单胞菌可能存在协同作用。
Acta Paediatr Scand. 1981 Sep;70(5):623-8. doi: 10.1111/j.1651-2227.1981.tb05757.x.
3
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.囊性纤维化患者呼吸道病毒感染与肺部恶化的关联
N Engl J Med. 1984 Dec 27;311(26):1653-8. doi: 10.1056/NEJM198412273112602.
4
Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis.病毒和嗜肺军团菌在患有囊性纤维化的年轻成年人呼吸道病情加重中的重要性。
Thorax. 1984 Feb;39(2):150-4. doi: 10.1136/thx.39.2.150.
5
The pediatrician's role in influenza control.
Pediatr Infect Dis. 1986 Nov-Dec;5(6):615-8. doi: 10.1097/00006454-198611000-00001.
6
What is a "pulmonary exacerbation" in cystic fibrosis?囊性纤维化中的“肺部加重”是什么?
J Pediatr. 1987 Dec;111(6 Pt 1):841-2. doi: 10.1016/s0022-3476(87)80198-1.
7
Viral infection in cystic fibrosis.囊性纤维化中的病毒感染。
J R Soc Med. 1986;79 Suppl 12(Suppl 12):19-22.
8
Antibiotic therapy in cystic fibrosis: evaluation of clinical trials.
J Pediatr. 1986 May;108(5 Pt 2):866-70. doi: 10.1016/s0022-3476(86)80759-4.
9
Serum C-reactive protein in assessment of pulmonary exacerbations and antimicrobial therapy in cystic fibrosis.血清C反应蛋白在囊性纤维化肺部加重期及抗菌治疗评估中的作用
J Pediatr. 1988 Jul;113(1 Pt 1):76-9. doi: 10.1016/s0022-3476(88)80533-x.
10
Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis.头孢他啶与安慰剂治疗囊性纤维化患者急性加重期呼吸疾病的随机试验
J Pediatr. 1987 Dec;111(6 Pt 1):907-13. doi: 10.1016/s0022-3476(87)80217-2.

与非细菌性感染相关的囊性纤维化急性加重的临床表现。

Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections.

作者信息

Pribble C G, Black P G, Bosso J A, Turner R B

机构信息

Department of Pediatrics, University of Utah School of Medicine, Salt Lake City.

出版信息

J Pediatr. 1990 Aug;117(2 Pt 1):200-4. doi: 10.1016/s0022-3476(05)80530-x.

DOI:10.1016/s0022-3476(05)80530-x
PMID:2380817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7130847/
Abstract

The purpose of this study was to determine whether acute pulmonary exacerbations of cystic fibrosis associated with nonbacterial infections are clinically distinguishable from other exacerbations. Eighty exacerbations in 54 patients were studied. Exacerbations associated with influenza (n = 8) were compared with those associated with other nonbacterial infections (n = 15) and those in which no nonbacterial infection was detected (n = 57). Patients with influenza had lower Shwachman scores and were more likely to be seropositive for C-reactive protein than patients in the other two groups. Patients with influenza had a mean decrease in forced expiratory volume per second of 26%, compared with test results obtained before the exacerbation. In contrast, the mean decrease in forced expiratory volume per second was 6% for other nonbacterial infections and 12% for the group without nonbacterial infection (p less than 0.05 for both comparisons). The forced expiratory flow in first 25% of vital capacity decreased 44% in the influenza group compared with 13% and 17% in the other two groups, respectively (p less than 0.01 for both comparisons). The influenza group also had a higher proportion of patients with at least a 20% decrease in forced expiratory volume per second and forced expiratory flow in first 25% of vital capacity than the other two groups had (p less than 0.05 for all comparisons). These data suggest that influenza is associated with severe exacerbations in patients with cystic fibrosis and support recommendations for efforts to prevent influenza in this population.

摘要

本研究的目的是确定与非细菌性感染相关的囊性纤维化急性肺部加重在临床上是否与其他加重情况可区分。对54例患者的80次加重情况进行了研究。将与流感相关的加重情况(n = 8)与与其他非细菌性感染相关的加重情况(n = 15)以及未检测到非细菌性感染的加重情况(n = 57)进行了比较。与其他两组患者相比,流感患者的施瓦克曼评分较低,C反应蛋白血清阳性的可能性更大。与加重前获得的测试结果相比,流感患者的一秒用力呼气量平均下降了26%。相比之下,其他非细菌性感染患者的一秒用力呼气量平均下降了6%,无非细菌性感染组为12%(两组比较p均小于0.05)。流感组肺活量前25%的用力呼气流量下降了44%,而其他两组分别下降了13%和17%(两组比较p均小于0.01)。与其他两组相比,流感组中一秒用力呼气量和肺活量前25%用力呼气流量至少下降20%的患者比例也更高(所有比较p均小于0.05)。这些数据表明,流感与囊性纤维化患者的严重加重相关,并支持在该人群中预防流感的建议。